✦ LIBER ✦

Effects of High-Dose Atorvastatin in Patients ≥65 Years of Age With Acute Coronary Syndrome (from the Myocardial Ischemia Reduction With Aggressive Cholesterol Lowering [MIRACL] Study)

✍ Scribed by Anders G. Olsson; Gregory G. Schwartz; Michael Szarek; Don Luo; Michael J. Jamieson

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of atorvastatin on risk of recurr

✍ S. Kinlay; G.G. Schwartz; A.G. Olsson 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 43 KB

Rationale and Design of the Myocardial I

✍ Gregory G Schwartz MD; PhD; Michael F Oliver MD; FRCP; Michael D Ezekowitz MD; P 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 143 KB

Cost-effectiveness of cholesterol-loweri

✍ Andrew M. Tonkin; Simon Eckermann; Harvey White; Denis Friedlander; Paul Glaszio 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 124 KB

Relationship of Oxidized Phospholipids a

✍ Alexander E. Fraley; Gregory G. Schwartz; Anders G. Olsson; Scott Kinlay; Michae 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 561 KB

Short-Term, High-Dose Atorvastatin Pretr

✍ Giuseppe Patti; Elisabetta Ricottini; Annunziata Nusca; Giuseppe Colonna; Vincen 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 811 KB

Comparison of Efficacy and Safety of Ato

✍ Matti J. Tikkanen; Ingar Holme; Nilo B. Cater; Michael Szarek; Ole Faergeman; Jo 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 205 KB